{"doi":"10.1056/nejmra1407390","title":"Applying Synthetic Lethality for the Selective Targeting of Cancer","abstract":null,"journal":"New England Journal of Medicine","year":2014,"id":624402,"datarank":0.8251887315817092,"base_score":5.501258210544727,"endowment":5.501258210544727,"self_citation_contribution":0.8251887315817092,"citation_network_contribution":0.0,"self_endowment_contribution":0.8251887315817092,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":244,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1614133,"name":"Alan List","orcid":null,"position":1,"is_corresponding":false},{"id":1392348,"name":"Ghulam J. Mufti","orcid":null,"position":2,"is_corresponding":false},{"id":1064713,"name":"Donal P. McLornan","orcid":"0000-0003-1224-091X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Applying Synthetic Lethality for the Selective Targeting of Cancer","abstract":"Synthetic lethality refers to the requirement that two defects be present for cell death to occur. When an agent damages DNA, its effects on the cell can be amplified if the efforts of the cell to repair the damage are inhibited. Clinical application of this idea is just beginning.","is_dataset_classified":null,"base_score":5.501258210544727,"endowment":5.501258210544727,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25354106","pmcid":null,"openalex_id":"https://openalex.org/W2161566038","authors":[],"funders":[],"total_grants":0,"fwci":12.9987,"citation_percentile":0.99296472,"influential_citations":0,"citation_trend":[{"year":2015,"count":30},{"year":2016,"count":32},{"year":2017,"count":38},{"year":2018,"count":32},{"year":2019,"count":21},{"year":2020,"count":26},{"year":2021,"count":16},{"year":2022,"count":10},{"year":2023,"count":10},{"year":2024,"count":10},{"year":2025,"count":11},{"year":2026,"count":8}],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://www.nejm.org/doi/pdf/10.1056/NEJMra1407390","host_type":"publisher"},{"url":"https://doi.org/10.1056/nejmra1407390","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25354106","host_type":"repository"}],"fields_of_study":["DNA Repair Mechanisms","PARP inhibition in cancer therapy","Cancer-related Molecular Pathways","Antineoplastic Agents","DNA Repair","Drug Discovery","Genes, Lethal","Genes, myc","Humans","Mutation","Neoplasms","Poly(ADP-ribose) Polymerase Inhibitors","Proto-Oncogene Proteins","Proto-Oncogene Proteins p21(ras)","ras Proteins"],"mesh_terms":["Poly(ADP-ribose) Polymerase Inhibitors","Antineoplastic Agents","DNA Repair","Genes, Lethal","Humans","Mutation","Neoplasms","Proto-Oncogene Proteins","Genes, myc","Proto-Oncogene Proteins p21(ras)","ras Proteins","Drug Discovery"],"keywords":["Synthetic lethality","Lethality","Medicine","Damages","Cancer","DNA damage","Cell","DNA repair","Cancer research","DNA","Toxicology","Genetics","Biology","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T03:40:58.736061Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}